In the healthcare debate, we've heard a lot about the equation between improving quality and cutting costs. But new research takes the opposite view that sometimes increased spending leads to better outcomes. Host Bruce Japsen, who also writes about healthcare for the Chicago Tribune, talks with Dr. Michael Ong, assistant professor of medicine in residence in the UCLA Division of General Internal Medicine & Health Services Research at the David Geffen School of Medicine, about his research.
Is Less More? Spending for Better Outcomes
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In the healthcare debate, we've heard a lot about the equation between improving quality and cutting costs. But new research takes the opposite view that sometimes increased spending leads to better outcomes. Host Bruce Japsen, who also writes about healthcare for the Chicago Tribune, talks with Dr. Michael Ong, assistant professor of medicine in residence in the UCLA Division of General Internal Medicine & Health Services Research at the David Geffen School of Medicine, about his research.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Navigating Myasthenia Gravis in Adolescents and Young Adults
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?